Takeda Hit With $885M Verdict Over Amitiza Generic Drug Delay Scheme 
UN Chief Proposes New U.N. Force Options for Lebanon After UNIFIL Mandate Ends 
Colombia Presidential Runoff Set as Abelardo De La Espriella Leads Ivan Cepeda in First Round 
RFK Jr. Expands CDC Vaccine Advisory Panel's Scope Amid Legal Battles 
Lebanon-Israel Partial Ceasefire Announced as Regional Tensions Remain High in 2026 
U.S. Supreme Court Allows Alabama’s Republican-Backed Congressional Map for 2026 Elections 
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 
Trump Administration Threatens Newark Airport International Travel Shutdown Over Immigration Dispute 
US Quantum Stocks Surge After $2 Billion Government Investment 
Putin’s ‘Russian Davos’ Draws U.S. Influencers, Officials, and Global Business Figures Amid Economic Struggles 
Denmark’s Mette Frederiksen Secures Third Term with New Centre-Left Coalition Government 
US Tightens Ebola Controls as Congo Outbreak Sparks Global Concern 
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access 
Canada Weighs Restoring Diplomatic Relations With Venezuela After Official Visit 
Trump Endorses Colombian Presidential Candidate Abelardo de la Espriella Ahead of Runoff Election 
Australia Sues 3M for Over A$2 Billion Over PFAS Firefighting Foam Contamination 
New World Screwworm Found Near U.S. Border Raises Threat to Cattle Industry and Beef Prices 
U.S. Health Secretary Robert F. Kennedy Jr. told lawmakers this week that he is open to sharing details about David Geier’s contract with the Department of Health and Human Services (HHS), signaling growing scrutiny over the controversial appointment. During a Senate Finance Committee hearing, Kennedy stated that the contract could be provided to senators before the end of the week, offering what may become the first clear explanation of Geier’s responsibilities within the agency.
David Geier, known for his long-standing anti-vaccine activism, is currently working as a contractor tied to the Centers for Disease Control and Prevention (CDC). According to federal records, he is listed as a senior data analyst within the HHS system. His involvement has raised concerns among lawmakers and public health experts, particularly given his history of promoting debunked claims linking vaccines to autism.
Senator Ben Ray Luján of New Mexico pressed Kennedy on whether the administration would also release the protocols guiding Geier’s work. Kennedy responded that such protocols are not yet in place but promised they would be shared once the vaccine safety review is completed. Kennedy has previously indicated that Geier is leading a review of CDC vaccine data, a move that has sparked debate due to Geier’s controversial background.
Geier’s past actions have added to the concern. He was previously fined in Maryland for practicing medicine without a license and for administering unsafe treatments to children with autism. Critics argue that his involvement in federal health initiatives could undermine public trust in vaccine safety.
The situation highlights ongoing tensions around vaccine policy, public health transparency, and the role of individuals with disputed scientific views in government positions. As pressure builds, the release of Geier’s HHS contract could play a key role in shaping public and political response to the administration’s handling of vaccine-related issues.
